Cargando…

OR28-03 Drug Repurposing Identifies Inhibitors of the Proteostasis Network to Augment Radioiodine Uptake in Combinatorial Approaches Targeting Thyroid Cancer

New combinatorial drug strategies are urgently needed to improve radioiodine (RAI) uptake and efficiently ablate thyroid cancer cells, thereby reducing the risk of recurrent disease. Drug repurposing offers the promise of identifying already approved compounds capable of inducing sodium iodide sympo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Read, Martin L, Brookes, Katie, Fletcher, Alice, Thornton, Caitlin E M, Alshahrani, Mohammed, Khan, Rashida, Nieto, Hannah R, Adcock, Holly V, Webster, Jamie R M, Cox, Liam, Alderwick, Luke J, Boelaert, Kristien, Smith, Vicki E, McCabe, Christopher J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208217/ http://dx.doi.org/10.1210/jendso/bvaa046.2135

Ejemplares similares

Dimerization of the Sodium/Iodide Symporter
por: Thompson, Rebecca J., et al.
Publicado: (2019)

The potential interaction between medical treatment and radioiodine treatment success: A systematic review
por: Zannat, Riazul, et al.
Publicado: (2023)

Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter
por: Read, Martin L., et al.
Publicado: (2022)

Hurthle Cells Adenoma With Distant Metastases Refractory to Radioiodine
por: Rosario, Pedro Weslley, et al.
Publicado: (2021)

Successful Management of Hyperthyroidism With Lithium and Radioiodine in a Patient With Previous Methimazole-Induced Agranulocytosis
por: Fantin, Esther H, et al.
Publicado: (2021)

SAT525 Long-Term Outcomes in Stage I Thyroid Cancer Without Radioiodine Remnant Ablation
por: Mubeen, Faiza, et al.
Publicado: (2023)

OR03-06 Transmembrane Water Channels Within The Tsh Receptor
por: Latif, Rauf, et al.
Publicado: (2023)

SAT-417 Personalized Treatment Planning for Radioiodine Therapy of Graves’ Disease;The Collar Therapy Indicator(CoTI)
por: Santhanam, Prasanna, et al.
Publicado: (2020)

MON-LB76 Impact of Age on Survival and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Cancer Patients
por: Buffet, Camille
Publicado: (2020)

FRI534 Influence Of Radioiodine Therapy Of Huge Thyroid Goiter On The Development Of Autoimmune Thyroid Disease In Retreated Patents
por: Skoczylas, Aleksander, et al.
Publicado: (2023)

OR26-05 Long-term Mortality And Cardiometabolic Effects Of Treatment For Hyperthyroidism: EGRET Study
por: Torlinska, Barbara, et al.
Publicado: (2023)

Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors
por: Nieto, Hannah R, et al.
Publicado: (2021)

SUN-430 A Prospective Clinical Trial on the Efficacy of Lithium as Adjuvant Therapy to Radioiodine in the Treatment of Hyperthyroidism (Railit Study)
por: Dharan, Shalini Sree, et al.
Publicado: (2020)

SAT-410 Long Term Evaluation of TSH Receptor Antibodies and Thyroid Stimulating Immunoglobulin After Radioiodine Therapy for Thyrotoxicosis
por: Marui, Suemi, et al.
Publicado: (2020)

ODP531 Worsening of pretibial myxedema following repeated doses of radioiodine treatment in a patient with hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

MON-558 Radioiodine Is Not Associated with Quality of Life Outcomes in Early Stage Thyroid Cancer Survivors, a Matched-Pair Analysis.
por: Chow, Kimberly, et al.
Publicado: (2019)

MON-443 SPECT/CT Localization of Incidental Diverticular Bleed After Radioiodine (i(131)) Therapy for Metastatic Thyroid Cancer
por: Doshi, Sejal B, et al.
Publicado: (2020)

MON-LB87 Recombinant Human TSH vs Thyroid Hormone Withdrawal Preparation for Radioiodine Ablation in Pediatric Differentiated Thyroid Cancer
por: Schumm, Max A, et al.
Publicado: (2020)

PSAT243 Late Versus Early Administration of Radioiodine Therapy for Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
por: Lincango Naranjo, Eddy P, et al.
Publicado: (2022)

OR32-03 mRNA Expression Based Tumor Behavior Prediction Models In Thyroid Nodules
por: Golding, Allan, et al.
Publicado: (2023)

OR18-03 Functional TSH Receptor Antibodies Are a Biomarker for Graves’ Disease - a Prospective Trial
por: Kahaly, George Jean, et al.
Publicado: (2020)

OR01-03 Thyroid Receptor Alpha Interacts with COUP-TFII in the Regulation of Postnatal Skeletal Muscle Regeneration
por: Aguiari, Paola, et al.
Publicado: (2020)

Effectiveness of Different Thyroid Stimulating Hormone Thresholds for Thyroid Hormone Withdrawal - Aided Radioiodine Ablation in Patients With Differentiated Thyroid Cancer: A Systematic Review and Meta - Analysis
por: Rojas, Tatiana, et al.
Publicado: (2021)

OR14-03 The Thyroid Hormone Receptor Beta Genotype Of The Fetus Influences The Maternal Thyroid Function During Pregnancy
por: Salas Lucia, Federico, et al.
Publicado: (2023)

OR21-03 Determining Novel Therapeutic Targets Using an in Vitro Model of TRb Tumor Suppression in Anaplastic Thyroid Cancer
por: Gillis, Noelle E, et al.
Publicado: (2020)

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
por: Kiyota, Naomi, et al.
Publicado: (2017)

MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer.
por: Fallahi, Poupak, et al.
Publicado: (2019)

Estimabl2: Is There a Need for Radioiodine Ablation in Low Risk Differentiated Thyroid Cancer (DTC) Patients?: Results From the French Randomized Phase III Prospective Trial on 776 Patients (NCT 01837745)
por: Leboulleux, Sophie, et al.
Publicado: (2021)

OR26-03 Treatment With Linsitinib, An IGF-1 Receptor Inhibitor, Prevents Disease Development And Progression In An Experimental Model Of Thyroid Eye Disease
por: Gulbins, Anne, et al.
Publicado: (2023)

Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries
por: la Cour, Jeppe Lerche, et al.
Publicado: (2016)

SAT526 Limited Utility of Routine Neck Ultrasound Follow-up in Advanced Stage Differentiated Thyroid Cancer
por: Munro, Vicki, et al.
Publicado: (2023)

Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib
por: Taylor, Matthew H., et al.
Publicado: (2021)

Manipulation of PBF/PTTG1IP Phosphorylation Status; a Potential New Therapeutic Strategy for Improving Radioiodine Uptake in Thyroid and Other Tumors
por: Smith, V. E., et al.
Publicado: (2013)

Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin
por: Watkins, Rachel J., et al.
Publicado: (2016)

Repurposing medicinal compounds for blood cancer treatment
por: McCabe, Bronagh, et al.
Publicado: (2015)

Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer
por: Read, Martin L., et al.
Publicado: (2017)

A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease
por: Taprogge, Jan, et al.
Publicado: (2021)

Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma
por: DE CREA, C., et al.
Publicado: (2014)

Aesthetic comparison between synthetic glue and subcuticular sutures in thyroid and parathyroid surgery: a single-blinded randomised clinical trial
por: ALICANDRI-CIUFELLI, M., et al.
Publicado: (2014)

Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations
por: Shin, Jung Hee, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3gm0frqbb033023797hbjej3qh